Key interindividual determinants in MDMA pharmacodynamics > GIAS | 2018 | PublicacionesAutor: Papaseit E. y otrosRevista: Expert Opin Drug Metab ToxicolFuente: tandfonline.com Volver a Publicaciones ← Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder? Acute Pharmacological Effects of 2C-B in Humans: An Observational Study →
